Brief Title
Norwegian Randomized Trial on Indocyanine Green Cholangiography Utility for Laparoscopic Cholecystectomy, Prestudy
Official Title
Norwegian Randomized Trial on Indocyanine Green Cholangiography Utility for Laparoscopic Cholecystectomy, Prestudy
Brief Summary
The purpose of this study is to compare different dosages and ways of administration of indocyanine green during fluorescent cholangiography in laparoscopic cholecystectomy. The study is randomized.
Study Type
Interventional
Primary Outcome
A questionnaire will be used to evaluate the surgeons experience.
Condition
Gall Stone
Intervention
Direct gallbladder injection of ICG intraoperatively
Study Arms / Comparison Groups
Direct gallbladder injection
Description: 2.5 mg of ICG will be injected directly into gallbladder intraoperatively.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
100
Start Date
October 1, 2022
Completion Date
December 2024
Primary Completion Date
December 2024
Eligibility Criteria
Inclusion Criteria: - Indication for laparoscopic cholecystectomy - Signed informed consent Exclusion Criteria: - Allergy to indocyanine green or iodine - Pregnancy or breast feeding
Gender
All
Ages
18 Years - 99 Years
Accepts Healthy Volunteers
No
Contacts
, +4769860000, [email protected]
Location Countries
Norway
Location Countries
Norway
Administrative Informations
NCT ID
NCT05376540
Organization ID
REK280193
Responsible Party
Sponsor
Study Sponsor
Ostfold Hospital Trust
Collaborators
Oslo University Hospital
Study Sponsor
, ,
Verification Date
January 2022